News

American Association of Individual Investors5d
Why Inhibikase Therapeutics, Inc.’s (IKT) Stock Is Down 5.30%
Inhibikase Therapeutics, Inc.’s IKT share price has dipped by 5.30%, which has investors questioning if this is right time to buy.
Yahoo Finance5d
MEDIPOST Co., Ltd. (078160.KQ)
298380.KQ ABL Bio Inc.
Yahoo Finance6d
Enzolytics, Inc. (ENZC)
At close: April 17 at 4:00:00 PM EDT ...